摘要
Extracorporeal membrane oxygenation has emerged as a viable alternative for stabilizing and improving critically ill patients in acute cardiovascular diseases.However,the weaning stage has been associated with a high morbidity and mortality rate.This makes searching for strategies that reduce failure in this final process necessary.Implementing a new approach must be tried and included in our protocols,seeking the patient’s well-being at all times.In this article,the authors discuss their point of view regarding potential pharmacological alternatives and the mechanism of action involved,which could decrease the mortality associated with this therapeutic.
